Simplex Trading’s Teladoc Health TDOC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.44M | Sell |
447,600
-104,200
| -19% | -$585K | ﹤0.01% | 1666 |
|
|
2025
Q4 | $3.86M | Sell |
551,800
-41,700
| -7% | -$326K | ﹤0.01% | 1478 |
|
|
2025
Q3 | $4.59M | Buy |
593,500
+341,700
| +136% | +$2.67M | ﹤0.01% | 1540 |
|
|
2025
Q2 | $2.19M | Sell |
251,800
-15,600
| -6% | -$113K | ﹤0.01% | 2015 |
|
|
2025
Q1 | $2.13M | Sell |
267,400
-250,700
| -48% | -$2.54M | ﹤0.01% | 1974 |
|
|
2024
Q4 | $4.71M | Sell |
518,100
-231,300
| -31% | -$2.23M | ﹤0.01% | 1513 |
|
|
2024
Q3 | $6.88M | Buy |
749,400
+379,800
| +103% | +$3.14M | ﹤0.01% | 1270 |
|
|
2024
Q2 | $3.61M | Sell |
369,600
-220,000
| -37% | -$2.68M | ﹤0.01% | 1669 |
|
|
2024
Q1 | $8.9M | Sell |
589,600
-159,800
| -21% | -$2.9M | 0.01% | 1203 |
|
|
2023
Q4 | $16.1M | Sell |
749,400
-93,100
| -11% | -$1.72M | 0.01% | 814 |
|
|
2023
Q3 | $15.7M | Buy |
842,500
+371,000
| +79% | +$8.66M | 0.01% | 701 |
|
|
2023
Q2 | $11.9M | Buy |
471,500
+4,100
| +0.9% | +$103K | 0.01% | 803 |
|
|
2023
Q1 | $12.1M | Sell |
467,400
-406,300
| -47% | -$10.9M | 0.01% | 804 |
|
|
2022
Q4 | $20.7M | Buy |
873,700
+1,600
| +0.2% | +$43.1K | 0.02% | 546 |
|
|
2022
Q3 | $22.1M | Buy |
872,100
+152,400
| +21% | +$5.35M | 0.03% | 481 |
|
|
2022
Q2 | $23.9M | Sell |
719,700
-150,600
| -17% | -$6.4M | 0.03% | 438 |
|
|
2022
Q1 | $62.8M | Sell |
870,300
-5,500
| -0.6% | -$396K | 0.06% | 240 |
|
|
2021
Q4 | $80.4M | Buy |
875,800
+457,000
| +109% | +$54.6M | 0.08% | 188 |
|
|
2021
Q3 | $69M | Buy |
418,800
+25,700
| +7% | +$3.74M | 0.06% | 202 |
|
|
2021
Q2 | $65.4M | Buy |
393,100
+391,146
| +20,018% | +$63.4M | 0.06% | 205 |
|
|
2021
Q1 | $35.5M | Sell |
1,954
-266
| -12% | -$61.7K | 0.06% | 177 |
|
|
2020
Q4 | $44.4M | Buy |
2,220
+740
| +50% | +$150K | 0.06% | 192 |
|
|
2020
Q3 | $32.4M | Buy |
1,480
+274
| +23% | +$58K | 0.04% | 241 |
|
|
2020
Q2 | $23M | Buy |
1,206
+131
| +12% | +$23K | 0.04% | 279 |
|
|
2020
Q1 | $16.7M | Buy |
1,075
+630
| +142% | +$73.3K | 0.03% | 272 |
|
|
2019
Q4 | $3.73M | Sell |
445
-59
| -12% | -$4.49K | 0.01% | 992 |
|
|
2019
Q3 | $3.41M | Buy |
504
+197
| +64% | +$13K | 0.01% | 945 |
|
|
2019
Q2 | $2.04M | Buy |
307
+109
| +55% | +$6.35K | 0.01% | 1301 |
|
|
2019
Q1 | $1.1M | Sell |
198
-33
| -14% | -$2.02K | ﹤0.01% | 1911 |
|
|
2018
Q4 | $1.15M | Sell |
231
-38
| -14% | -$2.33K | ﹤0.01% | 1524 |
|
|
2018
Q3 | $2.32M | Buy |
269
+30
| +13% | +$2.14K | 0.01% | 1126 |
|
|
2018
Q2 | $1.39M | Buy |
239
+176
| +279% | +$8.6K | 0.01% | 1462 |
|
|
2018
Q1 | $40K | Buy |
63
+10
| +19% | +$377 | ﹤0.01% | 2665 |
|
|
2017
Q4 | $35K | Sell |
53
-511
| -91% | -$17K | ﹤0.01% | 2780 |
|
|
2017
Q3 | $536K | Buy |
564
+385
| +215% | +$12.6K | 0.02% | 633 |
|
|
2017
Q2 | $83K | Sell |
179
-206
| -54% | -$6K | ﹤0.01% | 1920 |
|
|
2017
Q1 | $154K | Buy |
385
+356
| +1,228% | +$7.41K | 0.01% | 1414 |
|
|
2016
Q4 | $4K | Sell |
29
-5
| -15% | -$85 | ﹤0.01% | 4586 |
|
|
2016
Q3 | $4K | Buy |
+34
| New | +$596 | ﹤0.01% | 4518 |
|
|
2016
Q2 | – | Sell |
-33
| Closed | -$4K | – | 6434 |
|
|
2016
Q1 | $4K | Buy |
33
+4
| +14% | +$57 | ﹤0.01% | 4305 |
|
|
2015
Q4 | $22K | Buy |
+29
| New | +$535 | ﹤0.01% | 2607 |
|
Other funds holding TDOC
VPM
VCM
VC
Simplex Trading's TDOC Position: Q1 2026 in Review
Simplex Trading increased its Teladoc Health (TDOC) stake by 44% in Q1 2026, buying an estimated $567K and bringing the position to 332,811 shares worth $1.81M. The position accounts for ﹤0.01% of the portfolio, ranked #1906.
Simplex Trading first reported a position in TDOC in Q4 2015 and has held it in 19 quarters since. The position peaked at $14.3M in Q1 2021. 322 funds tracked by Wall St. Rank hold TDOC as of Q1 2026.
- Simplex Trading held 332,811 shares of Teladoc Health worth $1.81M as of Q1 2026.
- Simplex Trading bought 101,131 Teladoc Health shares in Q1 2026, an estimated $567K.
- Teladoc Health made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #1906 holding.
- Simplex Trading first reported a position in Teladoc Health in Q4 2015 and has held it in 19 quarters since.
- Simplex Trading's Teladoc Health position peaked at $14.3M in Q1 2021.
- 322 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2026.
Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.